One can not exclude that under inflammatory conditions the compensatory increase in SLPI and/or other protease inhibitors may reduce the severity of AAT deficiency by favourably affecting the overall protease/protease-inhibitor balance in AAT-deficient individuals. The gene discussed is SLPI; the disease is alpha 1-antitrypsin deficiency.